Rosecliff Acquisition Corp I Cl A (RCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RCLF | TMO | ISRG | DXCM | EW |
| Company | Rosecliff Acquisition Corp I Cl A | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Dexcom Inc | Edwards Lifesciences Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 12.19 | 579.84 | 380.00 | 127.22 | 85.85 |
| High | 13.00 | 579.84 | 384.47 | 129.22 | 86.95 |
| Low | 9.91 | 571.63 | 378.87 | 126.91 | 85.20 |
| Last | 11.57 | 572.38 | 381.36 | 128.37 | 85.25 |
| Change | -0.64 | +1.13 | +3.71 | +1.72 | +0.19 |
| % Change | -5.24% | +0.20% | +0.98% | +1.36% | +0.22% |
| Volume | 150,200 | 1,749,600 | 1,028,800 | 1,778,900 | 2,327,100 |
| 20-Day Average Volume | 269,060 | 1,437,555 | 1,473,430 | 2,961,450 | 2,989,750 |
| Previous Close | 12.21 | 571.25 | 377.65 | 126.65 | 85.06 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.22 | 566.87 | 377.87 | 133.31 | 88.02 |
| 20-Day Raw Stochastic | 24.76% | 70.89% | 60.04% | 27.99% | 18.21% |
| 20-Day Relative Strength | 52.83% | 51.63% | 51.12% | 46.40% | 41.97% |
| Weighted Alpha | +2.10 | +8.72 | +27.65 | +11.77 | +1.47 |
| Today's Opinion | 96% Buy | 56% Buy | 56% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 96% Buy | 56% Buy | 40% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 80% Buy | 80% Buy | 64% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.63% since 09/01/23 | -0.21% since 04/26/24 | +1.61% since 04/26/24 | +3.24% since 04/26/24 | -1.37% since 04/26/24 |
| Low | 9.91 on 09/11/23 | 565.49 on 05/02/24 | 367.39 on 05/02/24 | 123.07 on 04/29/24 | 83.50 on 05/01/24 |
| High | 19.50 on 09/07/23 | 581.90 on 05/01/24 | 384.47 on 05/03/24 | 129.22 on 05/03/24 | 87.21 on 04/29/24 |
| 1-Month | |||||
| %Chg | +9.05% since 08/11/23 | -0.63% since 04/03/24 | -0.54% since 04/03/24 | -7.32% since 04/03/24 | -8.35% since 04/03/24 |
| Low | 8.96 on 08/30/23 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 123.07 on 04/29/24 | 83.50 on 05/01/24 |
| High | 19.50 on 09/07/23 | 589.93 on 04/09/24 | 393.66 on 04/05/24 | 141.99 on 04/09/24 | 94.37 on 04/04/24 |
| 3-Month | |||||
| %Chg | +10.66% since 06/09/23 | +3.73% since 02/02/24 | -0.63% since 02/02/24 | +6.13% since 02/02/24 | -0.98% since 02/02/24 |
| Low | 8.96 on 08/30/23 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 113.05 on 02/28/24 | 82.53 on 02/07/24 |
| High | 19.50 on 09/07/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 142.00 on 03/26/24 | 96.12 on 03/28/24 |
| 6-Month | |||||
| %Chg | +14.33% since 03/09/23 | +25.87% since 11/03/23 | +36.92% since 11/03/23 | +31.72% since 11/03/23 | +27.11% since 11/03/23 |
| Low | 8.96 on 08/30/23 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 91.49 on 11/08/23 | 63.88 on 11/10/23 |
| High | 19.50 on 09/07/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 142.00 on 03/26/24 | 96.12 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 78,487 | 218,485,456 | 135,270,672 | 51,050,688 | 51,371,648 |
| Shares Outstanding, K | 6,784 | 381,714 | 354,706 | 397,684 | 602,600 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 3,622,300,000 | 6,004,800,000 |
| Annual Net Income | 11,040,000 | 5,995,000,000 | 1,798,000,000 | 541,500,000 | 1,402,400,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 1,890,600,000 | 921,000,000 | 1,598,200,000 |
| Last Quarter Net Income | -1,030,000 | 1,327,000,000 | 544,900,000 | 146,400,000 | 351,900,000 |
| 60-Month Beta | 0.02 | 0.80 | 1.39 | 1.23 | 1.10 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.32 on 04/25/24 | 0.66 on 04/25/24 |
| Latest Earnings Date | N/A | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.42 | 80.69 | 76.30 | 33.36 |